Carl D. Winberg

3.2k total citations
52 papers, 2.4k citations indexed

About

Carl D. Winberg is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Carl D. Winberg has authored 52 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 21 papers in Oncology and 19 papers in Genetics. Recurrent topics in Carl D. Winberg's work include Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Viral-associated cancers and disorders (15 papers). Carl D. Winberg is often cited by papers focused on Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Viral-associated cancers and disorders (15 papers). Carl D. Winberg collaborates with scholars based in United States, United Kingdom and South Korea. Carl D. Winberg's co-authors include Henry Rappaport, Bharat N. Nathwani, Khalil Sheibani, Jerome S. Burke, Dennis D. Weisenburger, Lawrence W. Diamond, Jonathan Ben‐Ezra, Anna M. Wu, Robert M. Bearman and William G. Swartz and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Carl D. Winberg

52 papers receiving 2.3k citations

Peers

Carl D. Winberg
Dennis H. Wright United Kingdom
Khalil Sheibani United States
Gerald E. Byrne United States
P G Isaacson United Kingdom
John G. Strickler United States
Dennis H. Wright United Kingdom
Carl D. Winberg
Citations per year, relative to Carl D. Winberg Carl D. Winberg (= 1×) peers Dennis H. Wright

Countries citing papers authored by Carl D. Winberg

Since Specialization
Citations

This map shows the geographic impact of Carl D. Winberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl D. Winberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl D. Winberg more than expected).

Fields of papers citing papers by Carl D. Winberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl D. Winberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl D. Winberg. The network helps show where Carl D. Winberg may publish in the future.

Co-authorship network of co-authors of Carl D. Winberg

This figure shows the co-authorship network connecting the top 25 collaborators of Carl D. Winberg. A scholar is included among the top collaborators of Carl D. Winberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl D. Winberg. Carl D. Winberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pullarkat, Vinod, et al.. (2001). Pathology of Autoimmune Myelofibrosis. American Journal of Clinical Pathology. 116(2). 211–216. 40 indexed citations
2.
Traweek, S. Thomas, et al.. (1993). High-Grade Transformation of Chronic Lymphocytic Leukemia and Low-Grade Non-Hodgkin’s Lymphoma:Genotypic Confirmation of Clonal Identity. American Journal of Clinical Pathology. 100(5). 519–526. 28 indexed citations
3.
Shin, Sung Sik, et al.. (1993). Immunohistologic studies of bone marrow biopsies on frozen sections: An analysis of 42 cases. Human Pathology. 24(1). 30–36. 4 indexed citations
4.
Shin, Sung Sik, et al.. (1992). Immunoarchitecture of normal human bone marrow: A study of frozen and fixed tissue sections. Human Pathology. 23(6). 686–694. 18 indexed citations
5.
6.
Wu, Anna M., Carl D. Winberg, Khalil Sheibani, et al.. (1990). Genotype and phenotype: A practical approach to the immunogenetic analysis of lymphoproliferative disorders. Human Pathology. 21(11). 1132–1141. 5 indexed citations
7.
Traweek, S. Thomas, Jonathan Ben‐Ezra, Rita M. Braziel, & Carl D. Winberg. (1990). The in-vitro response of CD2-positive acute myelogenous leukemia to proliferation and differentiation inducing agents. Leukemia Research. 14(5). 433–440. 7 indexed citations
8.
Koo, Chae H., Henry Rappaport, Khalil Sheibani, et al.. (1989). Imprint cytology of non-Hodgkin's lymphomas based on a study of 212 immunologically characterized cases: Correlation of touch imprints with tissue sections. Human Pathology. 20(12). 1–26. 24 indexed citations
9.
Sheibani, Khalil, Jerome S. Burke, William G. Swartz, Auayporn Nademanee, & Carl D. Winberg. (1988). Monocytoid b-cell lymphoma clinicopathologic study of 21 cases of a unique type of low-grade lymphoma. Cancer. 62(8). 1531–1538. 111 indexed citations
10.
Sheibani, Khalil, Bharat N. Nathwani, William G. Swartz, et al.. (1988). Variability in interpretation of immunohistologic findings in lymphoproliferative disorders by hematopathologists. A comprehensive statistical analysis of interobserver performance. Cancer. 62(4). 657–664. 15 indexed citations
11.
Winberg, Carl D., Khalil Sheibani, Jerome S. Burke, Anna M. Wu, & Henry Rappaport. (1988). T-cell-rich lymphoproliferative disorders morphologic and immunologic differential diagnoses. Cancer. 62(8). 1539–1555. 25 indexed citations
12.
Ben‐Ezra, Jonathan, Carl D. Winberg, Anna M. Wu, & Henry Rappaport. (1987). Leu-9 (CD 7) positivity in acute leukemias: a marker of T-cell lineage?. PubMed. 1(3). 147–56. 7 indexed citations
13.
Sheibani, Khalil, et al.. (1987). Distinction between Undifferentiated (Small Noncleaved) and Lymphoblastic Lymphoma. The American Journal of Surgical Pathology. 11(10). 779–787. 9 indexed citations
15.
Winberg, Carl D., et al.. (1987). A systematic approach to the immunohistologic classification of lymphoproliferative disorders. Human Pathology. 18(10). 1051–1062. 19 indexed citations
16.
Burke, Jerome S., Khalil Sheibani, Carl D. Winberg, & Henry Rappaport. (1987). Recognition of Hairy Cell Leukemia in a Spleen of Normal Weight: The Contribution of Immunohistoiogic Studies. American Journal of Clinical Pathology. 87(2). 276–281. 6 indexed citations
17.
Metter, Gerald E., Bharat N. Nathwani, Jerome S. Burke, et al.. (1985). Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies.. Journal of Clinical Oncology. 3(1). 25–38. 108 indexed citations
18.
Weisenburger, Dennis D., Bharat N. Nathwani, Carl D. Winberg, & Henry Rappaport. (1985). Multicentric angiofollicular lymph node hyperplasia: A clinicopathologic study of 16 cases. Human Pathology. 16(2). 162–172. 278 indexed citations
19.
Weisenburger, Dennis D., Bharat N. Nathwani, Lawrence W. Diamond, Carl D. Winberg, & Henry Rappaport. (1981). Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases. Cancer. 48(6). 1415–1425. 182 indexed citations
20.
Lewin, K., William R. Fair, Roy T. Steigbigel, Carl D. Winberg, & Michael J. Droller. (1976). Clinical and laboratory studies into the pathogenesis of malacoplakia.. Journal of Clinical Pathology. 29(4). 354–363. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026